Shi, Z., Shao, K., Wang, K., Xu, M., Yu, X., Xu, C., . . . Song, Z. (2025). Post-marketing safety of pralsetinib. International Journal of Clinical Pharmacy, 1-10. https://doi.org/10.1007/s11096-025-01917-z
Chicago-referens (17:e uppl.)Shi, Zheng, Keda Shao, Ke Wang, Manyi Xu, Xiayao Yu, Chunwei Xu, Qin Li, och Zhengbo Song. "Post-marketing Safety of Pralsetinib." International Journal of Clinical Pharmacy 2025: 1-10. https://doi.org/10.1007/s11096-025-01917-z.
MLA-referens (9:e uppl.)Shi, Zheng, et al. "Post-marketing Safety of Pralsetinib." International Journal of Clinical Pharmacy, 2025, pp. 1-10, https://doi.org/10.1007/s11096-025-01917-z.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.
